These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37467034)

  • 1. A "Bundle of Care" to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study.
    Jorgensen AL; Orrell C; Waitt C; Toh CH; Sekaggya-Wiltshire C; Hughes DA; Allen E; Okello E; Tatz G; Culeddu G; Asiimwe IG; Semakula JR; Mouton JP; Cohen K; Blockman M; Lamorde M; Pirmohamed M
    JMIR Res Protoc; 2023 Jul; 12():e46710. PubMed ID: 37467034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    Semakula JR; Mouton JP; Jorgensen A; Hutchinson C; Allie S; Semakula L; French N; Lamorde M; Toh CH; Blockman M; Sekaggya-Wiltshire C; Waitt C; Pirmohamed M; Cohen K
    PLoS One; 2020; 15(1):e0227458. PubMed ID: 31995565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range - study protocol for a randomized controlled trial.
    Marcatto LR; Sacilotto L; Bueno CT; Facin M; Strunz CM; Darrieux FC; Scanavacca MI; Krieger JE; Pereira AC; Santos PC
    BMC Cardiovasc Disord; 2016 Nov; 16(1):224. PubMed ID: 27855643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.
    An J; Niu F; Zheng C; Rashid N; Mendes RA; Dills D; Vo L; Singh P; Bruno A; Lang DT; Le PT; Jazdzewski KP; Aranda G
    J Manag Care Spec Pharm; 2017 Jun; 23(6):700-712. PubMed ID: 28530526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-Care International Normalized Ratio (INR) Monitoring Devices for Patients on Long-term Oral Anticoagulation Therapy: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(12):1-114. PubMed ID: 23074516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa.
    Ebrahim I; Bryer A; Cohen K; Mouton JP; Msemburi W; Blockman M
    S Afr Med J; 2018 May; 108(6):490-494. PubMed ID: 30004329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Health Information Technology-Enabled Panel Management Platform to Improve Anticoagulation Control in a Low-Income Patient Population: Protocol for a Quasi-Experimental Design.
    Fontil V; Kazi D; Cherian R; Lee SY; Sarkar U
    JMIR Res Protoc; 2020 Jan; 9(1):e13835. PubMed ID: 31929105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K-dependent anticoagulant use and level of anticoagulation control in sub-Saharan Africa: protocol for a retrospective cohort study.
    Mwita JC; Damasceno A; Chillo P; Ogah OS; Cohen K; Oyekunle A; Tefera E; Francis JM;
    BMJ Open; 2022 Feb; 12(2):e057166. PubMed ID: 35105600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
    Mwita JC; Francis JM; Pillay C; Ogah OS; Goshu DY; Agyekum F; Musonda JM; James MC; Tefera E; Kabo T; Ditlhabolo KI; Ndlovu K; Ayodele AY; Mikomangwa WP; Chillo P; Damasceno A; Folson AA; Oyekunle A; Tebuka E; Kalokola F; Forrest K; Dunn H; Karaye K; Jean-Pierre FL; Oljira CF; Assefa T; Taiwo TS; Nwafor CE; Omole O; Anakwue R; Cohen K
    J Thromb Thrombolysis; 2024 Apr; 57(4):613-621. PubMed ID: 38478250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing and Validating a Clinical Warfarin Dose-Initiation Model for Black-African Patients in South Africa and Uganda.
    Asiimwe IG; Waitt C; Sekaggya-Wiltshire C; Hutchinson C; Okello E; Zhang EJ; Semakula JR; Mouton JP; Cohen K; Blockman M; Lamorde M; Jorgensen AL; Pirmohamed M
    Clin Pharmacol Ther; 2021 Jun; 109(6):1564-1574. PubMed ID: 33280090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
    Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
    Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa.
    Sonuga BO; Hellenberg DA; Cupido CS; Jaeger C
    Afr J Prim Health Care Fam Med; 2016 May; 8(1):e1-8. PubMed ID: 27247158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).
    Smith DE; Xuereb CB; Pattison HM; Lip GY; Lane DA
    BMC Cardiovasc Disord; 2010 May; 10():21. PubMed ID: 20487528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review.
    Tadesse TA; Tegegne GT; Yadeta D; Chelkaba L; Fenta TG
    Thromb J; 2022 Oct; 20(1):58. PubMed ID: 36192776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International normalised ratio control in a non-metropolitan setting in Western Cape Province, South Africa.
    Prinsloo DN; Gould TJ; Viljoen CA; Basera W; Ntsekhe M
    S Afr Med J; 2021 Mar; 111(4):355-360. PubMed ID: 33944770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink.
    Macedo AF; Bell J; McCarron C; Conroy R; Richardson J; Scowcroft A; Sunderland T; Rotheram N
    Thromb Res; 2015 Aug; 136(2):250-60. PubMed ID: 26073321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.